Repertoire, a startup working on anti-cancer T-cell therapies, raised $189 million in its Series B funding round. With the new capital it will continue work on the therapies in its pipeline and enhance the capabilities of its immune response drug discovery platform.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.